{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T11:18:21Z","timestamp":1777288701681,"version":"3.51.4"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["1ZIAHG000068-15"],"award-info":[{"award-number":["1ZIAHG000068-15"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["ZIA HD008989"],"award-info":[{"award-number":["ZIA HD008989"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008028","name":"School of Medicine and Public Health, University of Wisconsin-Madison","doi-asserted-by":"publisher","award":["3T32GM008692"],"award-info":[{"award-number":["3T32GM008692"]}],"id":[{"id":"10.13039\/100008028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Niemann\u2013Pick disease type C1 (NPC1) is a rare, prematurely fatal lysosomal storage disorder which exhibits highly variable severity and disease progression as well as a wide-ranging age of onset, from perinatal stages to adulthood. This heterogeneity has made it difficult to obtain prompt diagnosis and to predict disease course. In addition, small NPC1 patient sample sizes have been a limiting factor in acquiring genome-wide transcriptome data. In this study, primary fibroblasts from an extensive cohort of 41 NPC1 patients were used to validate our previous findings that the lysosomal quantitative probe LysoTracker can be used as a predictor for age of onset and disease severity. We also examined the correlation between these clinical parameters and RNA expression data from primary fibroblasts and identified a set of genes that were significantly associated with lysosomal defects or age of onset, in particular neurological symptom onset. Hierarchical clustering showed that these genes exhibited distinct expression patterns among patient subgroups. This study is the first to collect transcriptomic data on such a large scale in correlation with clinical and cellular phenotypes, providing a rich genomic resource to address NPC1 clinical heterogeneity and discover potential biomarkers, disease modifiers, or therapeutic targets.<\/jats:p>","DOI":"10.1038\/s41598-022-06112-y","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T11:04:57Z","timestamp":1644404697000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Correlation of age of onset and clinical severity in Niemann\u2013Pick disease type C1 with lysosomal abnormalities and gene expression"],"prefix":"10.1038","volume":"12","author":[{"given":"Laura L.","family":"Baxter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn E.","family":"Watkins-Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole Y.","family":"Farhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frances M.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan K.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Forbes D.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8281-5120","authenticated-orcid":false,"given":"William J.","family":"Pavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1125-1281","authenticated-orcid":false,"given":"Jorge L.","family":"Rodriguez-Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"key":"6112_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-5-16","volume":"5","author":"MT Vanier","year":"2010","unstructured":"Vanier, M. T. Niemann\u2013Pick disease type C. Orphanet J. Rare Dis. 5, 16. https:\/\/doi.org\/10.1186\/1750-1172-5-16 (2010).","journal-title":"Orphanet J. Rare Dis."},{"key":"6112_CR2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ymgme.2016.12.003","volume":"120","author":"E Mengel","year":"2017","unstructured":"Mengel, E. et al. Differences in Niemann\u2013Pick disease Type C symptomatology observed in patients of different ages. Mol. Genet. Metab. 120, 180\u2013189. https:\/\/doi.org\/10.1016\/j.ymgme.2016.12.003 (2017).","journal-title":"Mol. Genet. Metab."},{"key":"6112_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1212\/CPJ.0000000000000399","volume":"7","author":"MC Patterson","year":"2017","unstructured":"Patterson, M. C. et al. Recommendations for the detection and diagnosis of Niemann\u2013Pick disease type C: An update. Neurol. Clin. Pract. 7, 499\u2013511. https:\/\/doi.org\/10.1212\/CPJ.0000000000000399 (2017).","journal-title":"Neurol. Clin. Pract."},{"key":"6112_CR4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1126\/science.277.5323.228","volume":"277","author":"ED Carstea","year":"1997","unstructured":"Carstea, E. D. et al. Niemann\u2013Pick C1 disease gene: Homology to mediators of cholesterol homeostasis. Science 277, 228\u2013231. https:\/\/doi.org\/10.1126\/science.277.5323.228 (1997).","journal-title":"Science"},{"key":"6112_CR5","doi-asserted-by":"publisher","first-page":"10079","DOI":"10.1073\/pnas.1611956113","volume":"113","author":"X Li","year":"2016","unstructured":"Li, X., Saha, P., Li, J., Blobel, G. & Pfeffer, S. R. Clues to the mechanism of cholesterol transfer from the structure of NPC1 middle lumenal domain bound to NPC2. Proc. Natl. Acad. Sci. USA 113, 10079\u201310084. https:\/\/doi.org\/10.1073\/pnas.1611956113 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"6112_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10545-014-9794-4","volume":"38","author":"MT Vanier","year":"2015","unstructured":"Vanier, M. T. Complex lipid trafficking in Niemann\u2013Pick disease type C. J. Inherit. Metab. Dis. 38, 187\u2013199. https:\/\/doi.org\/10.1007\/s10545-014-9794-4 (2015).","journal-title":"J. Inherit. Metab. Dis."},{"key":"6112_CR7","doi-asserted-by":"publisher","first-page":"15287","DOI":"10.1073\/pnas.0807328105","volume":"105","author":"RE Infante","year":"2008","unstructured":"Infante, R. E. et al. NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes. Proc. Natl. Acad. Sci. USA 105, 15287\u201315292. https:\/\/doi.org\/10.1073\/pnas.0807328105 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"6112_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-3-030-14265-0_8","volume":"1135","author":"SM Cologna","year":"2019","unstructured":"Cologna, S. M. & Rosenhouse-Dantsker, A. Insights into the molecular mechanisms of cholesterol binding to the NPC1 and NPC2 proteins. Adv. Exp. Med. Biol. 1135, 139\u2013160. https:\/\/doi.org\/10.1007\/978-3-030-14265-0_8 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"6112_CR9","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1074\/jbc.TM118.004165","volume":"294","author":"SR Pfeffer","year":"2019","unstructured":"Pfeffer, S. R. NPC intracellular cholesterol transporter 1 (NPC1)-mediated cholesterol export from lysosomes. J. Biol. Chem. 294, 1706\u20131709. https:\/\/doi.org\/10.1074\/jbc.TM118.004165 (2019).","journal-title":"J. Biol. Chem."},{"key":"6112_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.62382","author":"JL Rodriguez-Gil","year":"2021","unstructured":"Rodriguez-Gil, J. L. et al. Hepatocellular carcinoma as a complication of Niemann\u2013Pick disease type C1. Am. J. Med. Genet. A https:\/\/doi.org\/10.1002\/ajmg.a.62382 (2021).","journal-title":"Am. J. Med. Genet. A"},{"key":"6112_CR11","doi-asserted-by":"publisher","first-page":"8091","DOI":"10.1523\/JNEUROSCI.4173-14.2015","volume":"35","author":"M Praggastis","year":"2015","unstructured":"Praggastis, M. et al. A murine Niemann\u2013Pick C1 I1061T knock-in model recapitulates the pathological features of the most prevalent human disease allele. J. Neurosci. 35, 8091\u20138106. https:\/\/doi.org\/10.1523\/JNEUROSCI.4173-14.2015 (2015).","journal-title":"J. Neurosci."},{"key":"6112_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/jcm9010012","volume":"9","author":"JL Rodriguez-Gil","year":"2019","unstructured":"Rodriguez-Gil, J. L. et al. NPC1 deficiency in mice is associated with fetal growth restriction, neonatal lethality and abnormal lung pathology. J. Clin. Med. 9, 12. https:\/\/doi.org\/10.3390\/jcm9010012 (2019).","journal-title":"J. Clin. Med."},{"key":"6112_CR13","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/hep.20868","volume":"42","author":"EP Beltroy","year":"2005","unstructured":"Beltroy, E. P., Richardson, J. A., Horton, J. D., Turley, S. D. & Dietschy, J. M. Cholesterol accumulation and liver cell death in mice with Niemann\u2013Pick type C disease. Hepatology 42, 886\u2013893. https:\/\/doi.org\/10.1002\/hep.20868 (2005).","journal-title":"Hepatology"},{"key":"6112_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbalip.2013.09.010","volume":"1841","author":"CM Ramirez","year":"2014","unstructured":"Ramirez, C. M. et al. Ontogenic changes in lung cholesterol metabolism, lipid content, and histology in mice with Niemann\u2013Pick type C disease. Biochim. Biophys. Acta 1841, 54\u201361. https:\/\/doi.org\/10.1016\/j.bbalip.2013.09.010 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"6112_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067084","volume":"8","author":"BR Roszell","year":"2013","unstructured":"Roszell, B. R. et al. Pulmonary abnormalities in animal models due to Niemann\u2013Pick type C1 (NPC1) or C2 (NPC2) disease. PLoS ONE 8, e67084. https:\/\/doi.org\/10.1371\/journal.pone.0067084 (2013).","journal-title":"PLoS ONE"},{"key":"6112_CR16","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/ajmg.a.32642","volume":"149A","author":"R Spiegel","year":"2009","unstructured":"Spiegel, R. et al. The clinical spectrum of fetal Niemann\u2013Pick type C. Am. J. Med. Genet. A 149A, 446\u2013450. https:\/\/doi.org\/10.1002\/ajmg.a.32642 (2009).","journal-title":"Am. J. Med. Genet. A"},{"key":"6112_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1034\/j.1399-0004.2003.00147.x","volume":"64","author":"MT Vanier","year":"2003","unstructured":"Vanier, M. T. & Millat, G. Niemann\u2013Pick disease type C. Clin. Genet. 64, 269\u2013281. https:\/\/doi.org\/10.1034\/j.1399-0004.2003.00147.x (2003).","journal-title":"Clin. Genet."},{"key":"6112_CR18","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ymgme.2012.03.012","volume":"106","author":"MC Patterson","year":"2012","unstructured":"Patterson, M. C. et al. Recommendations for the diagnosis and management of Niemann\u2013Pick disease type C: An update. Mol. Genet. Metab. 106, 330\u2013344. https:\/\/doi.org\/10.1016\/j.ymgme.2012.03.012 (2012).","journal-title":"Mol. Genet. Metab."},{"key":"6112_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13023-018-0785-7","volume":"13","author":"T Geberhiwot","year":"2018","unstructured":"Geberhiwot, T. et al. Consensus clinical management guidelines for Niemann\u2013Pick disease type C. Orphanet J. Rare Dis. 13, 50. https:\/\/doi.org\/10.1186\/s13023-018-0785-7 (2018).","journal-title":"Orphanet J. Rare Dis."},{"key":"6112_CR20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/brain\/awl260","volume":"130","author":"M Sevin","year":"2007","unstructured":"Sevin, M. et al. The adult form of Niemann\u2013Pick disease type C. Brain 130, 120\u2013133. https:\/\/doi.org\/10.1093\/brain\/awl260 (2007).","journal-title":"Brain"},{"key":"6112_CR21","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1023\/a:1021259403196","volume":"25","author":"J Imrie","year":"2002","unstructured":"Imrie, J. et al. Niemann\u2013Pick disease type C in adults. J. Inherit. Metab. Dis. 25, 491\u2013500. https:\/\/doi.org\/10.1023\/a:1021259403196 (2002).","journal-title":"J. Inherit. Metab. Dis."},{"key":"6112_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10545-013-9626-y","volume":"37","author":"JE Wraith","year":"2014","unstructured":"Wraith, J. E. et al. Niemann\u2013Pick type C Suspicion Index tool: analyses by age and association of manifestations. J. Inherit. Metab. Dis. 37, 93\u2013101. https:\/\/doi.org\/10.1007\/s10545-013-9626-y (2014).","journal-title":"J. Inherit. Metab. Dis."},{"key":"6112_CR23","doi-asserted-by":"publisher","unstructured":"Bonnot, O., Klunemann, H. H., Velten, C., Torres Martin, J. V. & Walterfang, M. Systematic review of psychiatric signs in Niemann\u2013Pick disease type C. World J. Biol. Psychiatry 20, 320\u2013332. https:\/\/doi.org\/10.1080\/15622975.2018.1441548 (2019).","DOI":"10.1080\/15622975.2018.1441548"},{"key":"6112_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12883-015-0511-1","volume":"15","author":"J Imrie","year":"2015","unstructured":"Imrie, J., Heptinstall, L., Knight, S. & Strong, K. Observational cohort study of the natural history of Niemann\u2013Pick disease type C in the UK: A 5-year update from the UK clinical database. BMC Neurol. 15, 257. https:\/\/doi.org\/10.1186\/s12883-015-0511-1 (2015).","journal-title":"BMC Neurol."},{"key":"6112_CR25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/ajmg.b.30969","volume":"153B","author":"NM Yanjanin","year":"2010","unstructured":"Yanjanin, N. M. et al. Linear clinical progression, independent of age of onset, in Niemann\u2013Pick disease, type C. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B, 132\u2013140. https:\/\/doi.org\/10.1002\/ajmg.b.30969 (2010).","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"6112_CR26","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/S0140-6736(17)31465-4","volume":"390","author":"DS Ory","year":"2017","unstructured":"Ory, D. S. et al. Intrathecal 2-hydroxypropyl-beta-cyclodextrin decreases neurological disease progression in Niemann\u2013Pick disease, type C1: A non-randomised, open-label, phase 1\u20132 trial. Lancet 390, 1758\u20131768. https:\/\/doi.org\/10.1016\/S0140-6736(17)31465-4 (2017).","journal-title":"Lancet"},{"key":"6112_CR27","doi-asserted-by":"publisher","first-page":"8979","DOI":"10.3390\/ijms21238979","volume":"21","author":"V Pallottini","year":"2020","unstructured":"Pallottini, V. & Pfrieger, F. W. Understanding and treating Niemann\u2013Pick Type C disease: Models matter. Int. J. Mol. Sci. 21, 8979. https:\/\/doi.org\/10.3390\/ijms21238979 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"6112_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/s0024-3205(01)01384-4","volume":"70","author":"F Camargo","year":"2001","unstructured":"Camargo, F. et al. Cyclodextrins in the treatment of a mouse model of Niemann\u2013Pick C disease. Life Sci. 70, 131\u2013142. https:\/\/doi.org\/10.1016\/s0024-3205(01)01384-4 (2001).","journal-title":"Life Sci."},{"key":"6112_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006951","volume":"4","author":"CD Davidson","year":"2009","unstructured":"Davidson, C. D. et al. Chronic cyclodextrin treatment of murine Niemann\u2013Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. PLoS ONE 4, e6951. https:\/\/doi.org\/10.1371\/journal.pone.0006951 (2009).","journal-title":"PLoS ONE"},{"key":"6112_CR30","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1194\/jlr.M700525-JLR200","volume":"49","author":"B Liu","year":"2008","unstructured":"Liu, B., Li, H., Repa, J. J., Turley, S. D. & Dietschy, J. M. Genetic variations and treatments that affect the lifespan of the NPC1 mouse. J. Lipid Res. 49, 663\u2013669. https:\/\/doi.org\/10.1194\/jlr.M700525-JLR200 (2008).","journal-title":"J. Lipid Res."},{"key":"6112_CR31","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1073\/pnas.0810895106","volume":"106","author":"B Liu","year":"2009","unstructured":"Liu, B. et al. Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-\/- mouse. Proc. Natl. Acad. Sci. USA 106, 2377\u20132382. https:\/\/doi.org\/10.1073\/pnas.0810895106 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"6112_CR32","doi-asserted-by":"publisher","first-page":"9290","DOI":"10.1074\/jbc.M111.326405","volume":"287","author":"KB Peake","year":"2012","unstructured":"Peake, K. B. & Vance, J. E. Normalization of cholesterol homeostasis by 2-hydroxypropyl-beta-cyclodextrin in neurons and glia from Niemann\u2013Pick C1 (NPC1)-deficient mice. J. Biol. Chem. 287, 9290\u20139298. https:\/\/doi.org\/10.1074\/jbc.M111.326405 (2012).","journal-title":"J. Biol. Chem."},{"key":"6112_CR33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1203\/PDR.0b013e3181ee4dd2","volume":"68","author":"CM Ramirez","year":"2010","unstructured":"Ramirez, C. M. et al. Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann\u2013Pick type C1 mouse and markedly prolongs life. Pediatr. Res. 68, 309\u2013315. https:\/\/doi.org\/10.1203\/PDR.0b013e3181ee4dd2 (2010).","journal-title":"Pediatr. Res."},{"key":"6112_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13023-015-0240-y","volume":"10","author":"S Fecarotta","year":"2015","unstructured":"Fecarotta, S. et al. Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann\u2013Pick disease type C. Orphanet J. Rare Dis. 10, 22. https:\/\/doi.org\/10.1186\/s13023-015-0240-y (2015).","journal-title":"Orphanet J. Rare Dis."},{"key":"6112_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13023-020-01363-2","volume":"15","author":"MC Patterson","year":"2020","unstructured":"Patterson, M. C. et al. Treatment outcomes following continuous miglustat therapy in patients with Niemann\u2013Pick disease Type C: A final report of the NPC Registry. Orphanet J. Rare Dis. 15, 104. https:\/\/doi.org\/10.1186\/s13023-020-01363-2 (2020).","journal-title":"Orphanet J. Rare Dis."},{"key":"6112_CR36","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/NEN.0b013e31825414a6","volume":"71","author":"VM Stein","year":"2012","unstructured":"Stein, V. M. et al. Miglustat improves purkinje cell survival and alters microglial phenotype in feline Niemann\u2013Pick disease type C. J. Neuropathol. Exp. Neurol. 71, 434\u2013448. https:\/\/doi.org\/10.1097\/NEN.0b013e31825414a6 (2012).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"6112_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2021.100739","volume":"27","author":"S Curelaru","year":"2021","unstructured":"Curelaru, S., Zehavi, Y., Almagor, T. & Spiegel, R. Favorable outcomes following early onset oral miglustat in early infantile Niemann Pick Type C. Mol. Genet. Metab. Rep. 27, 100739. https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100739 (2021).","journal-title":"Mol. Genet. Metab. Rep."},{"key":"6112_CR38","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ymgme.2009.06.008","volume":"98","author":"JE Wraith","year":"2009","unstructured":"Wraith, J. E. et al. Recommendations on the diagnosis and management of Niemann\u2013Pick disease type C. Mol. Genet. Metab. 98, 152\u2013165. https:\/\/doi.org\/10.1016\/j.ymgme.2009.06.008 (2009).","journal-title":"Mol. Genet. Metab."},{"key":"6112_CR39","doi-asserted-by":"publisher","unstructured":"Kirkegaard, T. et al. Heat shock protein-based therapy as a potential candidate for treating the sphingolipidoses. Sci. Transl. Med. 8, 355ra118. https:\/\/doi.org\/10.1126\/scitranslmed.aad9823 (2016).","DOI":"10.1126\/scitranslmed.aad9823"},{"key":"6112_CR40","doi-asserted-by":"publisher","unstructured":"Vite, C. H. et al. Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann\u2013Pick type C1 disease. Sci. Transl. Med. 7, 276ra226. https:\/\/doi.org\/10.1126\/scitranslmed.3010101 (2015).","DOI":"10.1126\/scitranslmed.3010101"},{"key":"6112_CR41","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1194\/jlr.M000257","volume":"51","author":"B Liu","year":"2010","unstructured":"Liu, B. et al. Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid. J. Lipid Res. 51, 933\u2013944. https:\/\/doi.org\/10.1194\/jlr.M000257 (2010).","journal-title":"J. Lipid Res."},{"key":"6112_CR42","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ymgme.2013.06.010","volume":"110","author":"JL Rodriguez-Gil","year":"2013","unstructured":"Rodriguez-Gil, J. L. et al. A somatic cell defect is associated with the onset of neurological symptoms in a lysosomal storage disease. Mol. Genet. Metab. 110, 188\u2013190. https:\/\/doi.org\/10.1016\/j.ymgme.2013.06.010 (2013).","journal-title":"Mol. Genet. Metab."},{"key":"6112_CR43","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1172\/JCI72835","volume":"124","author":"D te Vruchte","year":"2014","unstructured":"te Vruchte, D. et al. Relative acidic compartment volume as a lysosomal storage disorder-associated biomarker. J. Clin. Invest. 124, 1320\u20131328. https:\/\/doi.org\/10.1172\/JCI72835 (2014).","journal-title":"J. Clin. Invest."},{"key":"6112_CR44","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1242\/dmm.024588","volume":"9","author":"W Westbroek","year":"2016","unstructured":"Westbroek, W. et al. A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease. Dis. Model Mech. 9, 769\u2013778. https:\/\/doi.org\/10.1242\/dmm.024588 (2016).","journal-title":"Dis. Model Mech."},{"key":"6112_CR45","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/hmg\/ddab194","volume":"30","author":"JL Rodriguez-Gil","year":"2021","unstructured":"Rodriguez-Gil, J. L. et al. Transcriptome of HPbetaCD-treated Niemann\u2013Pick disease type C1 cells highlights GPNMB as a biomarker for therapeutics. Hum. Mol. Genet. 30, 2456\u20132468. https:\/\/doi.org\/10.1093\/hmg\/ddab194 (2021).","journal-title":"Hum. Mol. Genet."},{"key":"6112_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147208","volume":"11","author":"AR Marques","year":"2016","unstructured":"Marques, A. R. et al. Gpnmb is a potential marker for the visceral pathology in Niemann\u2013Pick Type C disease. PLoS ONE 11, e0147208. https:\/\/doi.org\/10.1371\/journal.pone.0147208 (2016).","journal-title":"PLoS ONE"},{"key":"6112_CR47","doi-asserted-by":"publisher","unstructured":"Freshour, S. L. et al. Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts. Nucleic Acids Res. 49, D1144\u2013D1151. https:\/\/doi.org\/10.1093\/nar\/gkaa1084 (2021).","DOI":"10.1093\/nar\/gkaa1084"},{"key":"6112_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","volume":"4","author":"FM Platt","year":"2018","unstructured":"Platt, F. M., d\u2019Azzo, A., Davidson, B. L., Neufeld, E. F. & Tifft, C. J. Lysosomal storage diseases. Nat. Rev. Dis. Primers 4, 27. https:\/\/doi.org\/10.1038\/s41572-018-0025-4 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"6112_CR49","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1086\/425985","volume":"75","author":"T Dixon-Salazar","year":"2004","unstructured":"Dixon-Salazar, T. et al. Mutations in the AHI1 gene, encoding jouberin, cause Joubert syndrome with cortical polymicrogyria. Am. J. Hum. Genet. 75, 979\u2013987. https:\/\/doi.org\/10.1086\/425985 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"6112_CR50","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/ng1419","volume":"36","author":"RJ Ferland","year":"2004","unstructured":"Ferland, R. J. et al. Abnormal cerebellar development and axonal decussation due to mutations in AHI1 in Joubert syndrome. Nat. Genet. 36, 1008\u20131013. https:\/\/doi.org\/10.1038\/ng1419 (2004).","journal-title":"Nat. Genet."},{"key":"6112_CR51","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1523\/JNEUROSCI.2993-20.2021","volume":"41","author":"YC Hsiao","year":"2021","unstructured":"Hsiao, Y. C., Munoz-Estrada, J., Tuz, K. & Ferland, R. J. The transition zone protein AHI1 regulates neuronal ciliary trafficking of MCHR1 and its downstream signaling pathway. J. Neurosci. 41, 3932\u20133943. https:\/\/doi.org\/10.1523\/JNEUROSCI.2993-20.2021 (2021).","journal-title":"J. Neurosci."},{"key":"6112_CR52","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1093\/hmg\/ddp335","volume":"18","author":"YC Hsiao","year":"2009","unstructured":"Hsiao, Y. C. et al. Ahi1, whose human ortholog is mutated in Joubert syndrome, is required for Rab8a localization, ciliogenesis and vesicle trafficking. Hum. Mol. Genet. 18, 3926\u20133941. https:\/\/doi.org\/10.1093\/hmg\/ddp335 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"6112_CR53","doi-asserted-by":"publisher","unstructured":"Martin, K. B. et al. Identification of novel pathways associated with patterned cerebellar purkinje neuron degeneration in Niemann\u2013Pick disease, Type C1. Int. J. Mol. Sci. 21. https:\/\/doi.org\/10.3390\/ijms21010292 (2019).","DOI":"10.3390\/ijms21010292"},{"key":"6112_CR54","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/BF00227765","volume":"85","author":"Y Higashi","year":"1993","unstructured":"Higashi, Y., Murayama, S., Pentchev, P. G. & Suzuki, K. Cerebellar degeneration in the Niemann\u2013Pick type C mouse. Acta Neuropathol. 85, 175\u2013184. https:\/\/doi.org\/10.1007\/BF00227765 (1993).","journal-title":"Acta Neuropathol."},{"key":"6112_CR55","doi-asserted-by":"publisher","first-page":"15266","DOI":"10.1523\/JNEUROSCI.4650-09.2009","volume":"29","author":"P Duffy","year":"2009","unstructured":"Duffy, P. et al. Rho-associated kinase II (ROCKII) limits axonal growth after trauma within the adult mouse spinal cord. J. Neurosci. 29, 15266\u201315276. https:\/\/doi.org\/10.1523\/JNEUROSCI.4650-09.2009 (2009).","journal-title":"J. Neurosci."},{"key":"6112_CR56","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/s1044-7431(02)00035-0","volume":"22","author":"PP Monnier","year":"2003","unstructured":"Monnier, P. P., Sierra, A., Schwab, J. M., Henke-Fahle, S. & Mueller, B. K. The Rho\/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar. Mol. Cell Neurosci. 22, 319\u2013330. https:\/\/doi.org\/10.1016\/s1044-7431(02)00035-0 (2003).","journal-title":"Mol. Cell Neurosci."},{"key":"6112_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.636017","volume":"15","author":"AJ Weber","year":"2021","unstructured":"Weber, A. J. & Herskowitz, J. H. Perspectives on ROCK2 as a therapeutic target for Alzheimer\u2019s disease. Front. Cell Neurosci. 15, 636017. https:\/\/doi.org\/10.3389\/fncel.2021.636017 (2021).","journal-title":"Front. Cell Neurosci."},{"key":"6112_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.191","volume":"5","author":"JC Koch","year":"2014","unstructured":"Koch, J. C. et al. ROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS. Cell Death Dis. 5, e1225. https:\/\/doi.org\/10.1038\/cddis.2014.191 (2014).","journal-title":"Cell Death Dis."},{"key":"6112_CR59","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1172\/JCI132414","volume":"130","author":"E Ricker","year":"2020","unstructured":"Ricker, E. et al. Serine-threonine kinase ROCK2 regulates germinal center B cell positioning and cholesterol biosynthesis. J. Clin. Invest. 130, 3654\u20133670. https:\/\/doi.org\/10.1172\/JCI132414 (2020).","journal-title":"J. Clin. Invest."},{"key":"6112_CR60","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1161\/CIRCULATIONAHA.111.086041","volume":"126","author":"Q Zhou","year":"2012","unstructured":"Zhou, Q. et al. Rho-associated coiled-coil-containing kinase 2 deficiency in bone marrow-derived cells leads to increased cholesterol efflux and decreased atherosclerosis. Circulation 126, 2236\u20132247. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.086041 (2012).","journal-title":"Circulation"},{"key":"6112_CR61","doi-asserted-by":"publisher","unstructured":"Talaia, G., Amick, J. & Ferguson, S. M. Receptor-like role for PQLC2 amino acid transporter in the lysosomal sensing of cationic amino acids. Proc. Natl. Acad. Sci. USA 118. https:\/\/doi.org\/10.1073\/pnas.2014941118 (2021).","DOI":"10.1073\/pnas.2014941118"},{"key":"6112_CR62","doi-asserted-by":"publisher","unstructured":"Amick, J., Tharkeshwar, A. K., Talaia, G. & Ferguson, S. M. PQLC2 recruits the C9orf72 complex to lysosomes in response to cationic amino acid starvation. J. Cell Biol. 219. https:\/\/doi.org\/10.1083\/jcb.201906076 (2020).","DOI":"10.1083\/jcb.201906076"},{"key":"6112_CR63","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1126\/science.1220281","volume":"337","author":"B Liu","year":"2012","unstructured":"Liu, B., Du, H., Rutkowski, R., Gartner, A. & Wang, X. LAAT-1 is the lysosomal lysine\/arginine transporter that maintains amino acid homeostasis. Science 337, 351\u2013354. https:\/\/doi.org\/10.1126\/science.1220281 (2012).","journal-title":"Science"},{"key":"6112_CR64","doi-asserted-by":"publisher","first-page":"E3434","DOI":"10.1073\/pnas.1211198109","volume":"109","author":"A Jezegou","year":"2012","unstructured":"Jezegou, A. et al. Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapy. Proc. Natl. Acad. Sci. USA 109, E3434-3443. https:\/\/doi.org\/10.1073\/pnas.1211198109 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"6112_CR65","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.ajhg.2020.11.004","volume":"107","author":"MM Polovitskaya","year":"2020","unstructured":"Polovitskaya, M. M. et al. A recurrent gain-of-function mutation in CLCN6, encoding the ClC-6 Cl(-)\/H(+)-exchanger, causes early-onset neurodegeneration. Am. J. Hum. Genet. 107, 1062\u20131077. https:\/\/doi.org\/10.1016\/j.ajhg.2020.11.004 (2020).","journal-title":"Am. J. Hum. Genet."},{"key":"6112_CR66","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1007\/s12035-021-02291-3","volume":"58","author":"H He","year":"2021","unstructured":"He, H. et al. West syndrome caused by a chloride\/proton exchange-uncoupling CLCN6 mutation related to autophagic-lysosomal dysfunction. Mol. Neurobiol. 58, 2990\u20132999. https:\/\/doi.org\/10.1007\/s12035-021-02291-3 (2021).","journal-title":"Mol. Neurobiol."},{"key":"6112_CR67","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1097\/NEN.0b013e3181ffe742","volume":"69","author":"SN Pressey","year":"2010","unstructured":"Pressey, S. N. et al. Distinct neuropathologic phenotypes after disrupting the chloride transport proteins ClC-6 or ClC-7\/Ostm1. J. Neuropathol. Exp. Neurol. 69, 1228\u20131246. https:\/\/doi.org\/10.1097\/NEN.0b013e3181ffe742 (2010).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"6112_CR68","doi-asserted-by":"publisher","first-page":"13854","DOI":"10.1073\/pnas.0606137103","volume":"103","author":"M Poet","year":"2006","unstructured":"Poet, M. et al. Lysosomal storage disease upon disruption of the neuronal chloride transport protein ClC-6. Proc. Natl. Acad. Sci. USA 103, 13854\u201313859. https:\/\/doi.org\/10.1073\/pnas.0606137103 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"6112_CR69","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s00415-014-7619-x","volume":"262","author":"A Benussi","year":"2015","unstructured":"Benussi, A. et al. Phenotypic heterogeneity of Niemann\u2013Pick disease type C in monozygotic twins. J. Neurol. 262, 642\u2013647. https:\/\/doi.org\/10.1007\/s00415-014-7619-x (2015).","journal-title":"J. Neurol."},{"issue":"Suppl 1","key":"6112_CR70","doi-asserted-by":"publisher","first-page":"S221","DOI":"10.1007\/s10545-009-1173-1","volume":"32","author":"M Walterfang","year":"2009","unstructured":"Walterfang, M. et al. Gender dimorphism in siblings with schizophrenia-like psychosis due to Niemann\u2013Pick disease type C. J. Inherit. Metab. Dis. 32(Suppl 1), S221-226. https:\/\/doi.org\/10.1007\/s10545-009-1173-1 (2009).","journal-title":"J. Inherit. Metab. Dis."},{"key":"6112_CR71","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1086\/320606","volume":"68","author":"G Millat","year":"2001","unstructured":"Millat, G. et al. Niemann\u2013Pick C1 disease: Correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop. Am. J. Hum. Genet. 68, 1373\u20131385. https:\/\/doi.org\/10.1086\/320606 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"6112_CR72","doi-asserted-by":"publisher","unstructured":"Rodriguez-Gil, J. L. et al. Genetic background modifies phenotypic severity and longevity in a mouse model of Niemann\u2013Pick disease type C1. Dis. Model. Mech. 13. https:\/\/doi.org\/10.1242\/dmm.042614 (2020).","DOI":"10.1242\/dmm.042614"},{"key":"6112_CR73","doi-asserted-by":"publisher","unstructured":"Miyawaki, S., Yoshida, H., Mitsuoka, S., Enomoto, H. & Ikehara, S. A mouse model for Niemann\u2013Pick disease. Influence of genetic background on disease expression in spm\/spm mice. J. Hered. 77, 379\u2013384. https:\/\/doi.org\/10.1093\/oxfordjournals.jhered.a110265 (1986).","DOI":"10.1093\/oxfordjournals.jhered.a110265"},{"key":"6112_CR74","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s003350010013","volume":"11","author":"J Zhang","year":"2000","unstructured":"Zhang, J. & Erickson, R. P. A modifier of Niemann Pick C 1 maps to mouse chromosome 19. Mamm. Genome 11, 69\u201371. https:\/\/doi.org\/10.1007\/s003350010013 (2000).","journal-title":"Mamm. Genome"},{"key":"6112_CR75","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ymgmr.2018.05.001","volume":"15","author":"JF Calderon","year":"2018","unstructured":"Calderon, J. F. & Klein, A. D. Controversies on the potential therapeutic use of rapamycin for treating a lysosomal cholesterol storage disease. Mol. Genet. Metab. Rep. 15, 135\u2013136. https:\/\/doi.org\/10.1016\/j.ymgmr.2018.05.001 (2018).","journal-title":"Mol. Genet. Metab. Rep."},{"key":"6112_CR76","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.gene.2017.12.006","volume":"643","author":"CA Marshall","year":"2018","unstructured":"Marshall, C. A. et al. In Niemann\u2013Pick C1 mouse models, glial-only expression of the normal gene extends survival much further than do changes in genetic background or treatment with hydroxypropyl-beta-cyclodextrin. Gene 643, 117\u2013123. https:\/\/doi.org\/10.1016\/j.gene.2017.12.006 (2018).","journal-title":"Gene"},{"key":"6112_CR77","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.bbrc.2011.08.096","volume":"413","author":"J Parra","year":"2011","unstructured":"Parra, J. et al. Npc1 deficiency in the C57BL\/6J genetic background enhances Niemann\u2013Pick disease type C spleen pathology. Biochem. Biophys. Res. Commun. 413, 400\u2013406. https:\/\/doi.org\/10.1016\/j.bbrc.2011.08.096 (2011).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"6112_CR78","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10048-019-00600-6","volume":"21","author":"K Hetma\u0144czyk-Sawicka","year":"2020","unstructured":"Hetma\u0144czyk-Sawicka, K. et al. Changes in global gene expression indicate disordered autophagy, apoptosis and inflammatory processes and downregulation of cytoskeletal signalling and neuronal development in patients with Niemann\u2013Pick C disease. Neurogenetics 21, 105\u2013119. https:\/\/doi.org\/10.1007\/s10048-019-00600-6 (2020).","journal-title":"Neurogenetics"},{"key":"6112_CR79","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1089\/dna.2006.0570","volume":"26","author":"A De Windt","year":"2007","unstructured":"De Windt, A. et al. Gene set enrichment analyses revealed several affected pathways in Niemann\u2013Pick disease type C fibroblasts. DNA Cell Biol. 26, 665\u2013671. https:\/\/doi.org\/10.1089\/dna.2006.0570 (2007).","journal-title":"DNA Cell Biol."},{"key":"6112_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000019","volume":"1","author":"JV Reddy","year":"2006","unstructured":"Reddy, J. V., Ganley, I. G. & Pfeffer, S. R. Clues to neuro-degeneration in Niemann\u2013Pick type C disease from global gene expression profiling. PLoS ONE 1, e19. https:\/\/doi.org\/10.1371\/journal.pone.0000019 (2006).","journal-title":"PLoS ONE"},{"key":"6112_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015054","volume":"5","author":"FW Chen","year":"2010","unstructured":"Chen, F. W., Li, C. & Ioannou, Y. A. Cyclodextrin induces calcium-dependent lysosomal exocytosis. PLoS ONE 5, e15054. https:\/\/doi.org\/10.1371\/journal.pone.0015054 (2010).","journal-title":"PLoS ONE"},{"key":"6112_CR82","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.1073\/pnas.0914309107","volume":"107","author":"AI Rosenbaum","year":"2010","unstructured":"Rosenbaum, A. I., Zhang, G., Warren, J. D. & Maxfield, F. R. Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann\u2013Pick type C mutant cells. Proc. Natl. Acad. Sci. USA 107, 5477\u20135482. https:\/\/doi.org\/10.1073\/pnas.0914309107 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"6112_CR83","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/15548627.2017.1329081","volume":"13","author":"S Dai","year":"2017","unstructured":"Dai, S. et al. Methyl-beta-cyclodextrin restores impaired autophagy flux in Niemann\u2013Pick C1-deficient cells through activation of AMPK. Autophagy 13, 1435\u20131451. https:\/\/doi.org\/10.1080\/15548627.2017.1329081 (2017).","journal-title":"Autophagy"},{"key":"6112_CR84","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ymgme.2016.04.014","volume":"118","author":"Y Kondo","year":"2016","unstructured":"Kondo, Y. et al. In vitro evaluation of 2-hydroxyalkylated beta-cyclodextrins as potential therapeutic agents for Niemann\u2013Pick Type C disease. Mol. Genet. Metab. 118, 214\u2013219. https:\/\/doi.org\/10.1016\/j.ymgme.2016.04.014 (2016).","journal-title":"Mol. Genet. Metab."},{"key":"6112_CR85","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/stem.1917","volume":"33","author":"M Soga","year":"2015","unstructured":"Soga, M. et al. HPGCD outperforms HPBCD as a potential treatment for Niemann\u2013Pick disease type C during disease modeling with iPS cells. Stem Cells 33, 1075\u20131088. https:\/\/doi.org\/10.1002\/stem.1917 (2015).","journal-title":"Stem Cells"},{"key":"6112_CR86","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/B978-0-444-59565-2.00041-1","volume":"113","author":"MT Vanier","year":"2013","unstructured":"Vanier, M. T. Niemann\u2013Pick diseases. Handb. Clin. Neurol. 113, 1717\u20131721. https:\/\/doi.org\/10.1016\/B978-0-444-59565-2.00041-1 (2013).","journal-title":"Handb. Clin. Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06112-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06112-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06112-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T22:07:16Z","timestamp":1669327636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06112-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,9]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6112"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-06112-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,9]]},"assertion":[{"value":"26 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"William J Pavan, Jorge L. Rodriguez-Gil, and Forbes D. Porter are patent co-inventors: \u201cCompositions and methods for predicting age of onset of a lysosomal storage disease or a disease associated with a lysosomal defect.\u201d United States Patent number 9983200, dated May 29, 2018. Laura L. Baxter, Dawn E. Watkins-Chow, Nicholas L. Johnson, Nicole Y. Farhat, Frances M. Platt, and Ryan K. Dale declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2162"}}